{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for m root_names_stdName in Standardized Name (approximate match)
Status:
Investigational
Source:
USAN:MAVEROPEPIMUT-S COMPONENT SURA2.M [USAN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04631016: Phase 2 Interventional Completed Chronic Obstructive Pulmonary Disease (COPD)
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03976401: Phase 2 Interventional Completed NASH - Nonalcoholic Steatohepatitis
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:efbalropendekin alfa [INN]
Source URL:
Class:
PROTEIN
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
NCT01342263: Not Applicable Interventional Completed Ischemic Heart Disease
(2011)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:davoceticept [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04082936: Phase 1/Phase 2 Interventional Terminated Non-Hodgkin Lymphoma
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:dargistotug [INN]
Source URL:
Class:
PROTEIN